FDA Clearance Tracker · K213733
Ponto 5 SuperPower
Last checked: Nov 19, 2026Latest source record: Dec 16, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Dec 16, 2021
Substantially Equivalent
Time to decision
20 days
Received Nov 26, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K213733
- Device name
- Ponto 5 SuperPower
- Applicant
- Oticon Medical AB
- Applicant location
- Askim, SE
- Received
- Nov 26, 2021
- Decided
- Dec 16, 2021
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Hearing Aid, Bone Conduction (LXB)
- Device class
- Class II
- Regulation
- 21 CFR 874.3302
- Specialty
- Otolaryngology (ENT)
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LXB. The earliest in FDA's data is K855059, decided Apr 3, 1986.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K213733
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Oticon Medical AB
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261142 · Decided Aug 26, 2026 · 141 days after receipt
Device type: Hearing Aid, Bone Conduction, Implanted (MAH) · Otolaryngology (ENT)
K240614 · Decided Jul 10, 2024 · 127 days after receipt
Device type: Active Implantable Bone Conduction Hearing System (PFO) · Otolaryngology (ENT)
- Ponto 5 Mini510(k)
K211640 · Decided Aug 10, 2021 · 75 days after receipt
Device type: Hearing Aid, Bone Conduction (LXB) · Otolaryngology (ENT)
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.